A Non-interventional Study to Evaluate the Use of Pliaglis in Daily Practice
NCT01800474 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 582
Last updated 2022-08-25
Summary
A multe-center, non-interventional study in Europe to evaluate Pliaglis in daily practice
Conditions
- Health Knowledge, Attitudes, Practice
Sponsors & Collaborators
-
Galderma R&D
lead INDUSTRY
Principal Investigators
-
Max Murison, Dr. · National coordinating investigator
-
Maurizio Podda, Dr · National coordinating investigator
-
Hugues Cartier, Dr · National coordinating investigator
-
Carlos Guillén, Dr · National coordinating investigator
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-02-28
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- France
- Germany
- Spain
- United Kingdom
Study Locations
More Related Trials
-
Randomized Placebo-controlled Study of ISA247 in Plaque Psoriasis
NCT00244842 ·Status: COMPLETED ·Phase: PHASE3
-
Valchlor in the Treatment of Lichen Planopilaris
NCT03417141 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Elidel Cream on Erosive Oral Lichen Planus
NCT00130572 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis Patients
NCT00408187 ·Status: COMPLETED ·Phase: PHASE3
-
Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis
NCT02969018 ·Status: COMPLETED ·Phase: PHASE2
-
Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice
NCT01147874 ·Status: COMPLETED ·Phase: PHASE4
-
Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis
NCT01230138 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Deucravacitinib in Participants With Moderate-to-Severe Plaque Psoriasis in Germany
NCT06104644 ·Status: ACTIVE_NOT_RECRUITING
-
A 36-Week Extension to Protocol ISA04-03
NCT00258713 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)
NCT03988335 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris
NCT01320774 ·Status: COMPLETED
-
A Study of Real-World Experience of Psoriasis Patients Treated With Apremilast in Clinical Dermatology Practice
NCT02740218 ·Status: COMPLETED
-
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
NCT01871402 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With Psoriasis
NCT00563524 ·Status: COMPLETED ·Phase: PHASE1
-
STA-21 Topical Efficacy on Psoriasis
NCT01047943 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Treatment Protocols for Patients With Symptomatic Oral Lichen Planus
NCT04673916 ·Status: COMPLETED ·Phase: NA
-
Lichen Planus Mucosae at USZ, Efficacy of Oral Alitretinoin
NCT01538732 ·Status: UNKNOWN ·Phase: PHASE2
-
Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis
NCT02192164 ·Status: COMPLETED
-
Intra-dermal Injections of DLX105 Into Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris
NCT01595997 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis.
NCT00417820 ·Status: COMPLETED ·Phase: PHASE1
-
Pre-Shave Gel and Brush in Pseudofolliculitis Barbae
NCT03043534 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis
NCT01245140 ·Status: COMPLETED ·Phase: PHASE2
-
Study on Treatment for Patients With Symptomatic Oral Lichen Planus
NCT04718311 ·Status: COMPLETED ·Phase: NA
-
Satisfaction Survey - Cicaplast Mains
NCT05471934 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis
NCT00852761 ·Status: COMPLETED ·Phase: PHASE4